Numinus Wellness Inc. NUMIF

Company Overview

Numinus Wellness Inc. is a Canadian mental health care company focused on psychedelic-assisted therapy, behavioral health services, and related clinical support infrastructure. The company operates in the broader healthcare, mental health, and psychedelic medicine sectors, with activities spanning psychotherapy clinics, practitioner training, clinical research support, and operational infrastructure for regulated psychedelic treatments. Numinus has positioned itself as an integrated provider combining clinical care delivery with practitioner education and research-oriented capabilities tied to emerging psychedelic-assisted treatment models.

The company’s primary business lines have included psychotherapy and psychiatric services delivered through clinic networks, practitioner certification and training programs, and operational support for clinical trials and psychedelic-assisted treatment protocols. Historically, Numinus expanded through acquisitions and partnerships tied to ketamine-assisted therapy and psychedelic research infrastructure. The company was founded in 2020 and grew during a period of heightened investor and medical interest in psychedelic therapies for conditions such as depression, PTSD, anxiety, and substance use disorders. Public filings and company disclosures indicate that its strategic positioning has emphasized early participation in regulated psychedelic-assisted mental health care markets in Canada and the United States.